Key result
Orthologous mutagenesis at position 188 for either rat or human natriuretic peptide receptor-C results in a complete reversal of the receptor's pharmacology and ligand binding properties.
A single residue (188) in the natriuretic peptide receptor-C determines the distinct ligand binding pharmacology between rat and human variants, representing the first such finding for a single transmembrane domain receptor.
Answers are grounded in this paper and cite their sources.
Residue 188 dictates NPR-C species pharmacology; extends receptor structural insights but leaves open human therapeutic translation.
W e report the cloning and expressing of rat natriuretic peptide receptor4 (NPRmC), which binds naturally occurring and synthetic ligands with higher affinity than human NPR-C.Using ratmuman hybrids and site-directed mutagenesis, we identified residue 188,Ala for rat and ne for human, which modulates hormone binding.Orthologous mutagenesis at position 188 for either rNPR-C or hNPR-C results in a complete reversal of the pharmacology.To our knowledge, this is the first example of a single transmembrane domain receptor for which a single residue dictates the ligand binding properties; previous examples are limited to seven transmembrane receptors.Hypotensive control of cardiovascular homeostasis is i n p a r t regulated by the natriuretic peptides (NPs),' a family of three vasoactive hormones termed ANP, BNP, and CNP, which are produced primarily in the heart (ANP and BNP) (1) and endothelial cells (CNP) (2).Two classes of NP receptors (NPRs) have been defined: the receptor guanylyl cyclases NPR-A and NPR-B, which transduce most of the biological responses to NPs (3), and the clearance receptor (NPR-C), which lacks both the kinase-like and the guanylyl cyclase domains of NPR-A and NPR-B (4).NPR-C comprises >95% of the natriuretic peptides' binding sites in most tissues and mediates the metabolic clearance of the hormones (5).Bound ligand is internalized into an intracellular pool where lysosomal degradation of the hormone occurs, followed by recycling of the receptor to the cell surface.Numerous investigators recently gained evidence that NPR-C is not only restricted to the hormonal buffering, it also plays a role in feedback regulation ofANP secretion, and may couple to Gi to mediate phosphoinositide hydrolysis and inhibition of adenylyl cyclase (6). * The costs of publication of this article were defrayed in part by the "aduertisernent" in accordance with 18 U.S.C.Section 1734 solely to payment of page charges.This article must therefore be hereby marked indicate this fact.The n u c l e o ~i ~ sequence~s~ reported in this paper has been s u ~~i ~~e ~ to the ~n ~u n k ~/ E ~3 L Data Bank with accession number(s) L27339.
No takes yet. Share an insight, caveat, or question.
Engel et al. (1994) studied this question. Orthologous mutagenesis at position 188 was evaluated on Ligand binding properties and pharmacology. Orthologous mutagenesis at position 188 for either rat or human natriuretic peptide receptor-C results in a complete reversal of the receptor's pharmacology and ligand binding properties.
Synapse has enriched 10 related papers. Consider them for comparative context: